Shares of John Wiley & Sons, Inc. (NYSE:WLY – Get Free Report) traded up 6.4% during trading on Friday following a stronger than expected earnings report. The company traded as high as $46.57 ...

John Wiley & Sons, Inc. (NYSE:WLY – Get Free Report) gapped up before the market opened on Thursday after the company announced better than expected quarterly earnings. The stock had previously ...

Matthew Kissner; President and Chief Executive Officer; John Wiley & Sons Inc Christopher Caridi; Interim Chief Financial Officer; John Wiley & Sons Inc Good morning, and welcome to Wiley's Q3 ...

Good morning. And welcome to Wiley’s Q3 Fiscal 2025 Earnings Call. As a reminder, this conference is being recorded. At this time, I’d like to introduce Wiley’s Vice President of Investor ...

In trading on Friday, shares of John Wiley & Sons Inc. (Symbol: WLY) crossed above their 200 day moving average of $44.78, changing hands as high as $45.02 per share. John Wiley & Sons Inc. shares ...

HOBOKEN, N.J. (AP) — HOBOKEN, N.J. (AP) — John Wiley & Sons Inc. (WLY) on Thursday reported a loss of $23 million in its fiscal third quarter. The Hoboken, New Jersey-based company said it had ...

Shares of John Wiley & Sons climbed after the company posted significantly narrower losses for its fiscal third quarter and said it expects to meet the top end of its adjusted Ebitda margin target ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

On Friday afternoon, Fletcher “Flash” Wiley took to the Berklee Performance Center stage for his final act. The funeral service for Wiley, the prominent Boston attorney who shattered racial ...

More than 5 years after the American Society of Clinical Oncology warned of emerging disparities in precision medicine, ...

Dr. Thomas Mehrling (PhD in Pharmacology and MD, University of Frankfurt) brings 20 years of experience shaping the oncology landscape, with previous roles at Takeda, Mundipharma International and ...

Chronic spontaneous urticaria is an idiopathic syndrome defined by recurring itch, hives, or angioedema (or a combination of these symptoms) for more than 6 weeks. Remibrutinib, an oral, highly ...